Trial intelligence / Profile preview

Dapsone Gel 7.5% vs Aczone in Acne Vulgaris

NCT04015375Phase 3Completed

Sponsor
Torrent Pharmaceuticals Limited
Start
Jul 2019
Primary completion
Feb 2020
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of dapsone in acne vulgaris, sponsored by Torrent Pharmaceuticals Limited. Started Jul 2019; status: completed.

02

Drugs

dapsone
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT04015375.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04015375.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call